Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma

Surgical Neurology

Volumn 71, Issue 2, 2009, Pages 161-165

  Hong, Hyun Jong ^a   Kim, Young Jin ^b   Yi, Hyeong Joong ^c   Ko, Yong ^c   Oh, Suck Jun ^c   Kim, Jae Min ^d  

^a Seoul Medical Center   (South Korea)

^b Dankook University   (South Korea)

^c Hanyang University Medical Center   (South Korea)

^d Hanyang University Guri Hospital   (South Korea)

Author keywords

Basic fibroblast growth factor; Chronic subdural hematoma; Interleukin 6; Recurrence; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 6; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTER MEMBRANE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; SUBDURAL HEMATOMA; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149489185     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2008.01.023     Document Type: Article

References (23)

1. Bikfalvi A., Sauzeau C., Moukadiri H., et al. Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological efforts. J Cell Physiol 149 (1991) 50-59
2. El-Kadi H., Miele V.J., and Kaufman H.H. Prognosis of chronic subdural hematomas. Neurosurg Clin N Am 11 (2000) 553-567
3. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 32A (1996) 2413-2422
4. Fukuhara T., Gotoh M., Asari S., et al. The relationship between brain surface elastance and brain reexpansion after evacuation of chronic subdural hematoma. Surg Neurol 45 (1996) 570-574
5. Frati A., Salvati M., Mainiero F., et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg 100 (2004) 24-32
6. Fujisawa H., Ito H., Kashiwagi S., et al. Kallikrein-kinin system in chronic subdural haematomas: its role in vascular permeability and regulation of fibrinolysis and coagulation. J Neurol Neurosurg Psychiatry 59 (1995) 388-394
7. Ito H., Saito K., Yamamoto S., et al. Tissue-type plasminogen activator in the chronic subdural hematoma. Surg Neurol 30 (1988) 175-179
8. Katano H., Kamiya K., Mase M., et al. Tissue plasminogen activator in chronic subdural hematoma as a predictor of recurrence. J Neurosurg 104 (2006) 79-84
9. Koch A.E., Polverini P.J., Kunkel S.L., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1992) 1798-1801
10. Kwon T.H., Park Y.K., Lim D.J., et al. Chronic subdural hematoma: evaluation of the clinical significance of postoperative drainage volume. J Neurosurg 93 (2000) 796-799
11. Maruo N., Morita I., Shirao M., et al. IL-6 increases endothelial permeability in vitro. Endocrinology 131 (1992) 710-714
12. Murakami H., Hirose Y., Sagoh M., et al. Why do chronic subdural hematomas continue to grow slowly and not coagulate? Role of thrombomodulin in the mechanism. J Neurosurg 96 (2002) 877-884
13. Nakaguchi H., Tanishima T., and Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 95 (2001) 256-262
14. Nomura S., Kashiwagi S., Fujisawa H., et al. Characterization of local hyperfibrinolysis in chronic subdural hematomas by SDS-PAGE and immunoblot. J Neurosurg 81 (1994) 910-913
15. Oishi M., Toyama M., Tamatani S., et al. Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir (Tokyo) 41 (2001) 382-386
16. Shono T., Inamura T., Morioka T., et al. Vascular endothelial growth factor in chronic subdural hematomas. J Clin Neurosci 8 (2001) 411-415
17. Suzuki M., Endo S., Inada K., et al. Inflammatory cytokines locally elevated in chronic subdural haematoma. Acta Neurochir (Wien) (1998) 51-55
18. Suzuki M., Kudo A., Kitakami A., et al. Local hypercoagulative activity precedes hyperfibrinolytic activity in the subdural space during development of chronic subdural haematoma from subdural effusion. Acta Neurochir (Wien) 140 (1998) 261-266
19. Suzuki K., Takano S., Nose T., et al. Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J Trauma 46 (1999) 532-533
20. Vaquero J., Zurita M., and Cincu R. Vascular endothelial growth-permeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir (Wien) 144 (2002) 343-347
21. Weigel R., Hohenstein A., Schlickum L., et al. Angiotensin converting enzyme inhibition for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism. Neurosurgery 61 (2007) 788-793
22. Weigel R., Schilling L., and Schmiedek P. Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wien) 143 (2001) 811-819
23. Yamamoto H., Hirashima Y., Hamada H., et al. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg 98 (2003) 1217-1221